Korosec S

No ORCID on file · 1 paper in corpus · active 2022
2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.826411

While triggering oocyte maturation with GnRH agonist (GnRHa) seems to be safe and effective in terms of the risk of developing OHSS and the number of metaphase II oocytes, it nevertheless results in luteal phase deficiency. To date, strateg…